Results 181 to 190 of about 19,454 (209)
Some of the next articles are maybe not open access.

Seasonal Allergic Rhinitis

2018
Allergic rhinitis is a significant chronic health problem worldwide. It can be divided into seasonal and perennial classifications based on the timing of symptoms and the causative agents. Empiric treatment can be initiated without allergy testing, but testing is required for definitive diagnosis and consideration of certain trigger-specific therapies ...
Roua Azmeh, Mark S. Dykewicz
openaire   +2 more sources

Efficacy of pollen immunotherapy in seasonal allergic rhinitis

Pediatrics International, 2007
AbstractBackground: The efficacy of subcutaneous pollen immunotherapy has been documented in published double‐blind, placebo‐controlled studies related to treatment of seasonal allergic rhinitis. In the present study, subjective (symptom scores) and objective (nasal peak inspiratory flow, nasal smear, nasal biopsy) parameters were used to study the ...
Tanac, Remziye   +4 more
openaire   +4 more sources

Reduced Airway Absorption in Seasonal Allergic Rhinitis

American Journal of Respiratory and Critical Care Medicine, 1997
The common notion that increased mucosal absorption characterizes allergic and inflamed airways is poorly supported by physiologic in vivo data. We have now examined whether the airway mucosa of patients with seasonal allergic rhinitis develop a change in absorption during their active disease period.
Lennart Greiff   +5 more
openaire   +3 more sources

EFFECT OF DISODIUM CROMOGLYCATE ON SEASONAL ALLERGIC RHINITIS

The Lancet, 1971
Abstract Insufflation of disodium cromoglycate was compared with placebo insufflation in the prophylaxis of seasonal allergic rhinitis. The results of a double-blind trial in 27 patients suggest that insufflation of 10 mg. disodium cromoglycate into each nostril four times a day readily controls the symptoms of allergic rhinitis and considerably ...
E. Holopainen, Alf Backman, O.P. Salo
openaire   +3 more sources

Approaches to the Treatment of Seasonal Allergic Rhinitis

Southern Medical Journal, 1996
Between 15 and 30 million Americans have allergic rhinitis. Costs of diminished job and school performance extend beyond the financial burden of treatment, taking their toll in worker productivity and school absences. Therapeutic approaches include allergen avoidance, pharmaceuticals, and allergy immunotherapy.
openaire   +3 more sources

Fexofenadine or loratadine for seasonal allergic rhinitis? [PDF]

open access: possibleInpharma Weekly, 1999
Controversies concerning differences in efficacy between oral antihistamines exist, and the ideal second generation antihistamine for the treatment of seasonal allergic rhinitis has not yet been identified. The second generation antihistamines loratadine [‘Claritin’] and fexofenadine [‘Allegra’] are both available for the treatment of this condition ...
openaire   +1 more source

Ciclesonide for the treatment of seasonal allergic rhinitis

Expert Review of Clinical Immunology, 2011
Allergic rhinitis is considered one of the most common afflictions of humans, affecting up to 30% of the world's population, and is increasing in incidence. Primary symptoms, comorbid conditions and complications of this disorder exact a significant toll, resulting in an enormous physical, social and economic impact on society.
openaire   +3 more sources

Seasonal Allergic Rhinitis

Drugs, 1993
Improved treatment approaches for seasonal allergic rhinitis are based on the increasing knowledge about allergic inflammation and on the improved efficacy of newer drugs. The current management concept includes an individualised composition of the different approaches including allergen avoidance, topical treatment and the use of systemic drugs and ...
openaire   +3 more sources

Budesonide once-daily in seasonal allergic rhinitis

Current Medical Research and Opinion, 1991
A randomized, parallel group, double-blind multi-centre study was carried out in 342 patients with symptomatic seasonal allergic rhinitis to assess the efficacy and tolerability of intranasal budesonide administered either as a single morning dose of 400 micrograms or as a 200 micrograms twice-daily dose, morning and evening, for 4 weeks.
Mohan G   +4 more
openaire   +3 more sources

Hyposensitization in Allergic Seasonal Rhinitis as Evaluated by Rhinomanometry

Acta Oto-Laryngologica, 1978
Hyposensitization with Allpyral extracts was performed in 38 patients suffering from seasonal allergic rhinitis. An objective evaluation of the clinical course was obtained by rhinomanometry. After one year of hyposensitization therapy, 55% of the patients (21 out of 38) showed an improvement, and after the 3-year follow-up this figure had increased to
Gunnar Aschan   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy